Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CD69 | Q07108 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25518922 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL14051305 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL14025370 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL18102361 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311649 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL11946954 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL18708293 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311199 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311210 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL9914084 | 0.89 | ALDH1A1 (0.57) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780872-B2 | Oligosaccharide analytical standards | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | ACADEMIA SINICA (TW) | 2023-08-29 | — | — | US | disclosed |
| US-10961278-B2 | Vancomycin derivative, preparation method, pharmaceutical composition and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2021-03-30 | — | — | US | disclosed |
| US-20190153036-A1 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2019-05-23 | — | — | US | disclosed |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GLYCOM A/S (DK) | 2015-07-02 | — | — | US | disclosed |
| US-20130012466-A1 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-01-10 | — | — | US | disclosed |
| US-20120264924-A1 | Glycorandomization and Production of Novel Novobiocin Analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-8198419-B2 | Glycorandomization and production of novel erythromycin analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-06-12 | — | — | US | disclosed |
| US-20110124850-A1 | Glycorandomization and Production of Novel Vancomycin Analogs | THORSON JON | 2011-05-26 | — | — | US | disclosed |
| US-7348309-B2 | Glycorandomization and production of novel vancomycin analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124850-A1 | Glycorandomization and Production of Novel Vancomycin Analogs | NMT1, NMT2, B3GNT2 | ALDH1A1 1950/4885THRB 4071/4885MAPK1 4161/4885 |
| US-11780872-B2 | Oligosaccharide analytical standards | OSTC, FUT5, FUT6 | ALDH1A1 2232/4885THRB 1476/4885MAPK1 3330/4885 |
| US-10961278-B2 | Vancomycin derivative, preparation method, pharmaceutical composition and use thereof | PEPD, VIP, NRDC | ALDH1A1 3447/4885THRB 2955/4885MAPK1 2106/4885 |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GALE, SI, FUT6 | ALDH1A1 786/4885THRB 1340/4885MAPK1 3663/4885 |
| US-20130012466-A1 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | TUBB6, TUBB, TUBA1C | ALDH1A1 3136/4885THRB 4536/4885MAPK1 3599/4885 |
| US-20190153036-A1 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | PEPD, VIP, NRDC | ALDH1A1 3447/4885THRB 2955/4885MAPK1 2106/4885 |
| US-20120264924-A1 | Glycorandomization and Production of Novel Novobiocin Analogs | NMT2, NMT1, NAMPT | ALDH1A1 2259/4885THRB 4386/4885MAPK1 4166/4885 |
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | NGLY1, NRDC, MGAT3 | ALDH1A1 3782/4885THRB 128/4885MAPK1 2346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.